Nektar Therapeutics (NKTR)
NASDAQ: NKTR
· Real-Time Price · USD
40.18
4.20 (11.67%)
At close: Sep 05, 2025, 3:59 PM
40.40
0.55%
After-hours: Sep 05, 2025, 07:36 PM EDT
11.67% (1D)
| Bid | 38 |
| Market Cap | 764.17M |
| Revenue (ttm) | 74.93M |
| Net Income (ttm) | -122.27M |
| EPS (ttm) | -8.64 |
| PE Ratio (ttm) | -4.65 |
| Forward PE | -3 |
| Analyst | Strong Buy |
| Ask | 41 |
| Volume | 1,688,756 |
| Avg. Volume (20D) | 2,067,089 |
| Open | 35.96 |
| Previous Close | 35.98 |
| Day's Range | 34.62 - 40.45 |
| 52-Week Range | 6.45 - 40.45 |
| Beta | 1.07 |
About NKTR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NKTR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NKTR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Nektar Therapeutics is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+156.29%
Nektar Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
2 months ago
+12.1%
Nektar Therapeutics shares are trading higher after the company announced it will release top-line data from the 16-week induction period in the ongoing global Phase 2b REZOLVE-AD clinical trial of investigational rezpegaldesleukin on June 24, 2025.
